Bulk Manufacturer of Controlled Substances Application: PCAS-NANOSYN, LLC, 29336 [2015-12330]

Download as PDF 29336 Federal Register / Vol. 80, No. 98 / Thursday, May 21, 2015 / Notices appropriate mitigation measures were identified. The selected alternatives were determined to be the ‘‘environmentally preferred’’ course of action. Dated: January 30, 2015. Christine S. Lehnertz, Regional Director, Pacific West Region. [FR Doc. 2015–12376 Filed 5–20–15; 8:45 am] BILLING CODE 4312–FF–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–940] Certain Snowmobiles With Engines Having Exhaust TemperatureControlled Engine Technology and Components Thereof; Termination of an Investigation on the Basis of Withdrawal of the Complaint U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review the presiding administrative law judge’s (‘‘ALJ’’) initial determination (‘‘ID’’) (Order No. 11) granting the complainant’s motion to terminate the above-captioned investigation in its entirety on the basis of withdrawal of the complaint. The Commission has terminated the investigation. FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708–2532. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on December 24, 2014, based on a complaint filed by Arctic Cat Inc. of tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:28 May 20, 2015 Jkt 235001 Plymouth, MN (‘‘Arctic Cat’’). 79 FR 77526 (Dec. 24, 2014). The complaint alleged violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain snowmobiles with engines having exhaust temperature-controlled engine technology and components thereof by reason of infringement of certain claims of three United States patents. The Commission’s notice of investigation named as respondents Bombardier ´ Recreational Products, Inc. of Quebec, Canada; and BRP US Inc. of Sturtevant, Wisconsin. On April 23, 2015, Arctic Cat filed an unopposed motion to terminate the investigation in its entirety based upon withdrawal of the complaint. On April 24, 2015, the ALJ granted the motion as an ID (Order No. 11). No petitions for review were filed. The Commission has determined not to review the ID. The Commission has terminated the investigation. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: May 18, 2015. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2015–12301 Filed 5–20–15; 8:45 am] BILLING CODE 7020–02–P Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on December 11, 2014, PCAS-Nanosyn, LLC, 3331–B Industrial Drive, Santa Rosa, California 95403 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Oxycodone (9143) ........................ Oripavine (9330) ........................... Oxymorphone (9652) ................... Fentanyl (9801) ............................ Schedule II II II II The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of controlled substances in bulk form. Drug Enforcement Administration Dated: May 15, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [Docket No. DEA–392] [FR Doc. 2015–12330 Filed 5–20–15; 8:45 am] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: PCAS– NANOSYN, LLC ACTION: Notice of application. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration Registered bulk manufacturers of the affected basic classes and applicants therefore may file written comments or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 20, 2015. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing DATES: BILLING CODE 4410–09–P [Docket No. DEA–392] Importer of Controlled Substances Registration: Myoderm ACTION: Notice of registration. Myoderm applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Myoderm registration as an importer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated February 5, 2015, and published in the Federal Register on February 11, SUMMARY: E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 80, Number 98 (Thursday, May 21, 2015)]
[Notices]
[Page 29336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12330]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: PCAS-
NANOSYN, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes and 
applicants therefore may file written comments or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before July 20, 2015.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODXL, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
December 11, 2014, PCAS-Nanosyn, LLC, 3331-B Industrial Drive, Santa 
Rosa, California 95403 applied to be registered as a bulk manufacturer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Oripavine (9330)...........................  II
Oxymorphone (9652).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company is a contract manufacturer. At the request of the 
company's customers, it manufactures derivatives of controlled 
substances in bulk form.

    Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-12330 Filed 5-20-15; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.